Drug Screening Laboratory Services Market by Type (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair, and Others), End Users (Retail, Oil & Gas, Transportation, Staffing, Government, and Other Workplaces), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021-2028

Drug Screening Laboratory Services Market Analysis

The drug screening laboratory services market is predicted to garner $10,944.1 million in the 2021-2028 timeframe, growing from $4,584.9 million in 2020 at a healthy CAGR of 12.8%.

Market Synopsis

Inclination of millennials towards the consumption of alcohol and drugs is expected to accelerate the growth of drug screening laboratory services market.  

However, increased awareness regarding harmful effects of consuming drugs and alcohol is likely to hinder the market growth.

According to the regional analysis of the market, the Asia-Pacific drug screening laboratory services market is anticipated to grow at a CAGR of 13.10% by generating a revenue of $2,737.90 million during the review period.

Drug Screening Services Overview

Drug screening services involve examining and analyzing the traces of drugs and alcohol by collecting urine, hair, or blood samples from a person’s body. The main reason for drug screening is to identify drug addicts and treat them, and to avoid any king of accident and mishappenings.

Impact Analysis of COVID-19 on the Drug Screening Laboratory Services Market

The novel coronavirus pandemic has had a devastating effect on several industries, including the drug screening laboratory services market. The coronavirus infection is highly communicable. Therefore, to control the spread of infection many hospitals, clinics & nursing homes and institutions have postponed various surgeries, regular appointments, therapies and others. These delayed medical services have adversely affected drug screening laboratory services and have altered needs for laboratory personnel, reagents, and analyzers. Due to lockdowns, the companies have opted for work from home facility for their employees. Hence, the employers are unable to conduct their employees’ drugs and alcohol screening tests. Also, because of shutdown, various drug screening laboratories have either closed or have transformed themselves into COVID-19 testing centers. This has decreased the market share and has hindered the growth of drug screening laboratory services market. Apart from this, other factors such as high unemployment rate, and labor’s migration to their homelands have reduced the workforces in the companies and drug testing and screening centers. This has reduced the drug testing rate and adversely impacted the market growth.

Inclination of People towards Drugs is Projected to Drive Drug Screening Laboratory Services Market

Consumption of drugs among millennials owing to prevalence of anxiety, depression and inferiority complex is expected to drive the market of drugs screening laboratory services in the predicted timeframe. Trend of consuming drugs, alcohols and overdoses of prescribed medicines are increasing at a fast pace. Many people consume drugs and alcohol under the influence of their outer environment and friend circle and soon they become addicted. For instance, according to the news ‘Statistics: Drugs and substance abuse in India’ published in ‘Development Channel’ in 2019, approximately 60 lakh people in India suffer from opioid overuse, and more than 8.5 lakh people inject drugs into themselves and thus are drug addicts. Likewise, according to the World Drug Report 2017, the United Nations Office on Drugs and Crime (UNODC) estimated that nearly 29.5 million people were affected by drug use disorders all over the world. The drug screening laboratory services plays an important role in conducting tests to measure the amount of drugs and alcohol present in the person’s body. The employers of big organizations regularly conducts drug screening tests for their employees to monitor their health status and maintain a positive and productive working environment. This factor is likely to surge the growth of the market in the forecast time frame.

To know more about drug screening laboratory services market drivers, get in touch with our analysts here.

Rise in Health Awareness about the Ill-effects of Drugs to Restrain the Market

Adoption of a healthy lifestyle and increased awareness about the harmful effects of drugs and alcohol consumption is expected to restrain the market growth of drug screening laboratory services in the forecast timeframe. Various advertisements, campaigns, road shows and skits are organized by the government, local authorities and clubs in the academic institutes that highlights the adverse effects of drug consumption. Owing to this many people have stopped consuming drugs. Thus, this initiative will severely affect the market growth.

Advances in Technology and Testing Methods will Serve Various Opportunities for the Manufacturing Industries in the Market

 Continuous innovation and advancements in the testing methods used for drug testing and screening is expected to provide a boost to the growth of the market in the near future. Currently, urine, blood and hair sample is collected to test if the person has consumed drugs or is a drug addict. These methods measures the level and traces of drugs present in the blood stream of a person. This method is very tiresome and the results take time to come. Therefore, new technique is developed by the companies to make the drug testing process simpler. For instance, according  to an article published in ‘American Addiction Centers’ in February 2021, a new technology ‘paper spray mass spectrometry’ is developed which analyzes the molecules present in a fingerprint. As the person’s body metabolizes drugs, it excretes molecules which can easily be detected in the fingerprints by using paper spray mass spectrometry. This innovation is anticipated to impede the market growth in the coming years.

To know more about drug screening laboratory services market opportunities, get in touch with our analysts here.

[TYPEGRAPH]

Source: Research Dive Analysis

The workplace drug testing sub-segment is predicted to have a dominating market share in the global market and is expected to register a revenue of $8,635.50 million during the forecast period. This growth is projected to be due to increased consumption of drugs among the employees due to high work load, performance pressure, low self-esteem, depression, and many more.

[SAMPLETYPEGRAPH]

Source: Research Dive Analysis

The urine sub-segment of market is projected to have the fastest growth and it is projected to surpass $8937.4 million by 2028, with an increase from $3,647.40 million in 2020. This growth is attributed to increased adoption of point-of-care devices and easy drug testing. The urine samples can be collected easily and a wide rand of consumed drugs can be detected. The sample also provides a wide detection window which helps in tracing drugs for nearly 90 days after consumption.

[ENDUSERGRAPH]

Source: Research Dive Analysis

The government sub-segment of the drug screening laboratory services market is predicted to have rapid growth and it is expected to surpass $2,807.50 million by 2028, with an increase from $1,125.60 million in 2020 owing to strict rules by the government to test their employees for drug consumption and drug testing at workplace. Due to presence of drug addicts at the workplace, the employers have to suffer a lot in terms of financial losses, production losses, and others. Therefore, to control these, the government has set some regulations for conducting regular drug tests for the employees to constantly monitor their health status.

[REGIONGRAPH]

Source: Research Dive Analysis

The Market for Drug Screening Service Laboratory in North America to be the Most Dominant and Fastest

The North America drug screening laboratory services market accounted $1,839.10million in 2020 and is projected to register a revenue of $4,599.60 million by 2028. This growth is due to high government funding for drugs test and increased consumption of alcohol and drugs among the millennials.  For instance, the government in the U.S has allowed the drug testing of employees in both private and public sector companies.

Competitive Scenario in the Drug Screening Service Laboratory Market

The companies involved in the drug screening laboratory services market are Abbott Laboratories, Quest Diagnostics, Clinical Reference Laboratory, Inc, Laboratory Corporation of America Holdings, Cordant Health Solutions, Acm Global Laboratories, Omega Laboratories, Inc., Millennium Health, Precision Diagnostics, and Psychemedics.

Porter’s Five Forces Analysis for the Drug Screening Laboratory Services Market

• Bargaining Power of Suppliers: The manufacturing companies require best quality reagents and analyzers which can give accurate drug test results. Knowing this, the suppliers can demand a high cost for their supplies. 
  Hence, the bargaining power of suppliers is high.
• Bargaining Power of Buyers: Buyers, in case of drug screening laboratory services market, have to compromise on the cost of the products as the suppliers will demand high cost for a good product.
  Hence, the bargaining power of buyers is low.
• Threat of New Entrants: Startups entering market face a tough competition with already established brands in the market in terms of quality product and loyal customers. 
  As a result, the threat of the new entrants is moderate.
• Threat of Substitutes: Quick product manufacturing along with the best quality being offered in the market by companies attract customers. However, brand loyalty among consumers does not allow them to switch to different brand easily.
  Therefore, the threat of substitutes is low.
• Competitive Rivalry in the Market: The manufacturing companies are launching their products with latest and advanced technology. 
  Therefore, competitive rivalry in the market is high.

CHAPTER 1:INTRODUCTION

1.1.Research methodology

1.1.1.Desk research
1.1.2.Real-time insights and validation
1.1.3.Forecast model
1.1.4.Assumptions & forecast parameters

1.1.4.1.Assumptions
1.1.4.2.Forecast parameters

CHAPTER 2:EXECUTIVE SUMMARY

2.1.360° summary
2.2.Type trends
2.3.Sample Type trends
2.4.End user trends

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key takeaways

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.2.2.1.Top winning strategies, by year
3.2.2.2.Top winning strategies, by development
3.2.2.3.Top winning strategies, by company

3.2.3.Top player positioning

3.3.Porter's five forces analysis
3.4.Market dynamics
3.5.Drivers
3.6.Restraints
3.7.Opportunities
3.8.Technology landscape
3.9.Regulatory landscape
3.10.Market value chain analysis
3.11.Strategic overview

CHAPTER 4:IMPACT OF COVID19 ON DRUG SCREENING LABORATORY SERVICES MARKET

4.1.Introduction

4.2.COVID-19 health assessment
4.3.Impact of COVID-19 on the global economy
4.4.Impact of COVID-19 on global drug screening laboratory services market

4.4.1.Technological impact
4.4.2.Investment scenario

4.5.Drug screening laboratory services market size and forecast, by region, 2020-2028

CHAPTER 5:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET, BY TYPE

5.1.Overview

5.1.1.Market size and forecast, by type

5.2.Workplace drug testing

5.2.1.Key market trends, growth factors and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market share analysis, by country

5.3.Clinical toxicological testing

5.3.1.Key market trends, growth factors and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country

CHAPTER 6:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE

6.1.Overview

6.1.1.Market size and forecast, by sample type

6.2.Urine

6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market share analysis, by country

6.3.Oral fluid

6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market share analysis, by country

6.4.Hair

6.4.1.Key market trends, growth factors and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market share analysis, by country

6.5.Others

6.5.1.Key market trends, growth factors and opportunities
6.5.2.Market size and forecast, by region
6.5.3.Market share analysis, by country

CHAPTER 7:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET BY END USER

7.1.Overview

7.1.1.Market size and forecast, by type

7.2.Retail

7.2.1.Key market trends, growth factors and opportunities
7.2.2.Market size and forecast, by region
7.2.3.Market share analysis, by country

7.3.Oil & Gas

7.3.1.Key market trends, growth factors and opportunities
7.3.2.Market size and forecast, by region
7.3.3.Market share analysis, by country

7.4.Transportation

7.4.1.Key market trends, growth factors and opportunities
7.4.2.Market size and forecast, by region
7.4.3.Market share analysis, by country

7.5.Staffing

7.5.1.Key market trends, growth factors and opportunities
7.5.2.Market size and forecast, by region
7.5.3.Market share analysis, by country

7.6.Government

7.6.1.Key market trends, growth factors and opportunities
7.6.2.Market size and forecast, by region
7.6.3.Market share analysis, by country

7.7.Other workplaces

7.7.1.Key market trends, growth factors and opportunities
7.7.2.Market size and forecast, by region
7.7.3.Market share analysis, by country

CHAPTER 8:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast, by region

8.2.North America

8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by type
8.2.3.Market size and forecast, by sample type
8.2.4.Market size and forecast, by end-user
8.2.5.Market size and forecast, by country

8.2.6.U.S. 

8.2.6.1.Market size and forecast, by type
8.2.6.2.Market size and forecast, by sample type
8.2.6.3.Market size and forecast, by end-user

8.2.7.Canada

8.2.7.1.Market size and forecast, by type
8.2.7.2.Market size and forecast, by sample type
8.2.7.3.Market size and forecast, by end user

8.2.8.Mexico

8.2.8.1.Market size and forecast, by type
8.2.8.2.Market size and forecast, by sample type
8.2.8.3.Market size and forecast, by end user

8.3.Europe

8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by type
8.3.3.Market size and forecast, by sample type
8.3.4.Market size and forecast, by end-user
8.3.5.Market size and forecast, by country

8.3.6.Germany

8.3.6.1.Market size and forecast, by type
8.3.6.2.Market size and forecast, by sample type
8.3.6.3.Market size and forecast, by end user

8.3.7.UK

8.3.7.1.Market size and forecast, by type
8.3.7.2.Market size and forecast, by sample type
8.3.7.3.Market size and forecast, by end user

8.3.8.France

8.3.8.1.Market size and forecast, by type
8.3.8.2.Market size and forecast, by sample type
8.3.8.3.Market size and forecast, by end user

8.3.9.Italy

8.3.9.1.Market size and forecast, by type
8.3.9.2.Market size and forecast, by sample type
8.3.9.3.Market size and forecast, by end user

8.3.10.Spain

8.3.10.1.Market size and forecast, by type
8.3.10.2.Market size and forecast, by sample type
8.3.10.3.Market size and forecast, by end user

8.3.11.Rest of Europe

8.3.11.1.Market size and forecast, by type
8.3.11.2.Market size and forecast, by sample type
8.3.11.3.Market size and forecast, by end user

8.4.Asia-Pacific

8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by type
8.4.3.Market size and forecast, by sample type
8.4.4.Market size and forecast, by end user
8.4.5.Market size and forecast, by country

8.4.6.China

8.4.6.1.Market size and forecast, by type
8.4.6.2.Market size and forecast, by sample type
8.4.6.3.Market size and forecast, by end user

8.4.7.Japan

8.4.7.1.Market size and forecast, by type
8.4.7.2.Market size and forecast, by sample type
8.4.7.3.Market size and forecast, by end user

8.4.8.Australia

8.4.8.1.Market size and forecast, by type
8.4.8.2.Market size and forecast, by sample type
8.4.8.3.Market size and forecast, by end user

8.4.9.South Korea

8.4.9.1.Market size and forecast, by type
8.4.9.2.Market size and forecast, by sample type
8.4.9.3.Market size and forecast, by end user

8.4.10.India

8.4.10.1.Market size and forecast, by type
8.4.10.2.Market size and forecast, by sample type
8.4.10.3.Market size and forecast, by end user

8.4.11.Rest of Asia-Pacific

8.4.11.1.Market size and forecast, by type
8.4.11.2.Market size and forecast, by sample type
8.4.11.3.Market size and forecast, by end user

8.5.LAMEA

8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by type
8.5.3.Market size and forecast, by sample type
8.5.4.Market size and forecast, by end user
8.5.5.Market size and forecast, by country

8.5.6.Latin America

8.5.6.1.Market size and forecast, by type
8.5.6.2.Market size and forecast, by sample type
8.5.6.3.Market size and forecast, by end user

8.5.7.Middle East

8.5.7.1.Market size and forecast, by type
8.5.7.2.Market size and forecast, by sample type
8.5.7.3.Market size and forecast, by end user

8.5.8.Africa

8.5.8.1.Market size and forecast, by type
8.5.8.2.Market size and forecast, by sample type
8.5.8.3.Market size and forecast, by end user

CHAPTER 9:COMPANY PROFILES

9.1.Abbott Laboratories

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments

9.2.Quest Diagnostics

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments

9.3.Clinical Reference Laboratory, Inc

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Product portfolio
9.3.4.Key strategic moves and developments

9.4.Laboratory Corporation of America Holdings

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business Segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments

9.5.Cordant Health Solutions

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Product portfolio
9.5.4.Key strategic moves and developments

9.6.Psychemedics Corporation

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Product portfolio
9.6.4.Business performance
9.6.5.Key strategic moves and developments

9.7.ACM Global Laboratories

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Product portfolio
9.7.4.Key strategic moves and development

9.8.Omega Laboratories

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Product portfolio
9.8.4.Key strategic moves and developments

9.9.Millennium Health

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Product portfolio
9.9.4.Key strategic moves and developments

9.10.Precision Diagnostics

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Product portfolio

* Taxes/Fees, If applicable will be added during checkout. All prices in USD.